EcoDrugPlus

Toll Like Receptor 2

Ensembl ID : ENSPPRG00000018231
Gene Symbol: TLR2
4 Cross references
251 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSPPRG00000011574
Gene Symbol: TLR4
4 Cross references
127 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSPPRG00000012499
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSPPRG00000011696
Gene Symbol: TLR8
3 Cross references
200 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSPPRG00000002798
Gene Symbol: TLR9
3 Cross references
82 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSPPRG00000020934
Gene Symbol: TAAR1
4 Cross references
602 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSPPRG00000012591
Gene Symbol: TGFBR1
4 Cross references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSPPRG00000022957
Gene Symbol: TRPA1
4 Cross references
226 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSPPRG00000007515
Gene Symbol: TRPM8
2 Cross references
157 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSPPRG00000009839
Gene Symbol: TRPV1
4 Cross references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSPPRG00000013016
Gene Symbol: TSPO
4 Cross references
126 Possible Orthologues:

Transthyretin

Ensembl ID : ENSPPRG00000005939
Gene Symbol: TTR
4 Cross references
164 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).